Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRIDEX CORPIRIX · Entity 7882 | Director | December 16, 2025 | December 18, 2025 |
| NATUS MEDICAL INCBABY · Entity 125256 | Director | May 16, 2018 | May 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRIDEX CORP
Report date December 16, 2025 · Filed December 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 251,550 |
Reported balance
After 2025-12-16 transaction · row 1
1 source rowRow 1 · 2025-12-16 · Purchase · Acquired 2,000 · Balance 251,550 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 69,300 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 69,300 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 81,150 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 81,150 F1: The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.
NATUS MEDICAL INC
Report date May 16, 2018 · Filed May 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 94,402 |
Reported balance
After 2018-05-16 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-05-16 · Exercise / conversion · Acquired 5,000 · Balance 94,402 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 89,402 |
Reported balance
After 2018-05-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-05-16 · Sale · Disposed 5,000 · Balance 89,402 F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 92,402 |
Reported balance
After 2018-05-16 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-05-16 · Exercise / conversion · Acquired 3,000 · Balance 92,402 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 89,402 |
Reported balance
After 2018-05-16 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2018-05-16 · Sale · Disposed 3,000 · Balance 89,402 F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-08 | IndirectBy Family Trust | 0 |
Reported balance
After 2018-05-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-05-16 · Exercise / conversion · Disposed 5,000 · Balance 0 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $24.50 · Expires 2020-06-05 | IndirectBy Family Trust | 0 |
Reported balance
After 2018-05-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-05-16 · Exercise / conversion · Disposed 3,000 · Balance 0 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 30,410 |
Reported balance
Holding disclosure · report date 2018-05-16 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 30,410 |
| Common Stock, $0.001 par vale per shareSEC Table I · non-derivative | IndirectBy Spouse | 4,150 |
Reported balance
Holding disclosure · report date 2018-05-16 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 4,150 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2025 Filed Dec 18, 2025 19:55 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 2,000 | $1.01 | $2,019.80 |
DisclosureSEC source: 0001193125-25-324454 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,550 Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 19:44 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-320670 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,550 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $0.9885, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 16:58 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 20,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-318776 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,674 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9205 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 16:58 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 9,080 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-318776 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,754 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9508 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 19:56 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 21,843 | $0.97 | $21,087.23 |
DisclosureSEC source: 0001193125-25-285971 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,674 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 19:56 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 28,157 | $0.97 | $27,244.71 |
DisclosureSEC source: 0001193125-25-285971 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,831 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9367 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 23:08 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 12,024 | $1.18 | $14,229.20 |
DisclosureSEC source: 0000950170-25-110257 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,674 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.1899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 17:44 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 20,000 | $0.97 | $19,372.00 |
DisclosureSEC source: 0000950170-25-086645 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,650 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9519 to $0.9798, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 13, 2025 Filed Jun 25, 2025 00:17 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0000950170-25-089701 · ownership.xml · derivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-13 F1 · security: This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3. F3 · derivative.exercise_date: The shares are subject to vesting according to the following schedule: 1/48 of the total number of shares subject to the option shall vest on July 13, 2025, and each month thereafter, such that the option shall be fully vested on the earlier of (i) the four-year anniversary of the grant date or (ii) the Company's 2029 annual meeting of stockholders. Read SEC document |
| June 13, 2025 Filed Jun 25, 2025 00:17 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock (right to buy) · Derivative | 53,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0000950170-25-089701 · ownership.xml · derivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2032-06-13 F1 · security: This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3. F2 · derivative.exercise_date: All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 17:28 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 20,000 | $0.97 | $19,494.00 |
DisclosureSEC source: 0000950170-25-085972 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,650 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 17:28 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $0.96 | $9,627.00 |
DisclosureSEC source: 0000950170-25-085972 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,650 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.952 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 15, 2025 Filed May 16, 2025 17:38 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 2,500 | $1.00 | $2,502.50 |
DisclosureSEC source: 0000950170-25-073287 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,650 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0 to $1.005, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 14, 2025 Filed May 16, 2025 17:38 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 15,000 | $1.10 | $16,506.00 |
DisclosureSEC source: 0000950170-25-073287 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,150 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.085 to $1.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 19:16 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 19,710 | $1.21 | $23,784.06 |
DisclosureSEC source: 0000950170-25-060953 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,150 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 19:16 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 290 | $1.24 | $359.60 |
DisclosureSEC source: 0000950170-25-060953 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,440 Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 23:10 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $1.08 | $10,831.00 |
DisclosureSEC source: 0000950170-25-057602 · ownership.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,150 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.1052, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 23:10 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $1.05 | $10,540.00 |
DisclosureSEC source: 0000950170-25-057602 · ownership.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,150 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 23:46 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 91 | $4.65 | $423.15 |
DisclosureSEC source: 0001209191-19-026043 · doc4.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,990 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| March 24, 2019 Filed Mar 25, 2019 21:08 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 88 | $4.38 | $385.44 |
DisclosureSEC source: 0001209191-19-021195 · doc4.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,081 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| February 24, 2019 Filed Feb 25, 2019 23:16 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 108 | $4.77 | $514.62 |
DisclosureSEC source: 0001209191-19-013172 · doc4.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,169 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| January 24, 2019 Filed Jan 26, 2019 00:25 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 107 | $4.60 | $492.20 |
DisclosureSEC source: 0001209191-19-005436 · doc4.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,277 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:42 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 4,325 | $4.48 | $19,376.00 |
DisclosureSEC source: 0001209191-19-002558 · doc4.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,384 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 02:17 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 91 | $4.07 | $370.37 |
DisclosureSEC source: 0001704739-18-000061 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,709 F1 · shares: These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 01:55 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $4.34 | $43,443.00 |
DisclosureSEC source: 0001704739-18-000056 · edgar.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,800 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 00:16 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $4.71 | $47,144.00 |
DisclosureSEC source: 0001704739-18-000050 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.67 to $4.7599, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 24, 2018 Filed Dec 14, 2018 01:55 UTC | IRIDEX CORP IRIX · Entity 7882 | Tax withholdingCommon Stock | 1,462 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001704739-18-000056 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,800 F1 · shares: Reflects unreported shares withheld through November 24, 2018 in exempt dispositions to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and performance-based restricted stock units and does not represent sales by the Reporting Person. Determination of the number of shares withheld was based upon the closing prices of the Issuer's Common Stock on the dates withheld. F1 · price: Reflects unreported shares withheld through November 24, 2018 in exempt dispositions to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and performance-based restricted stock units and does not represent sales by the Reporting Person. Determination of the number of shares withheld was based upon the closing prices of the Issuer's Common Stock on the dates withheld. F2 · balance_after: Reflects the transfer by the reporting person of 13,538 shares of Common Stock, previously reported as owned directly, to William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common (the "Moore Trust"). Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 21:10 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $6.56 | $65,600.00 |
DisclosureSEC source: 0001704739-18-000043 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.40 to $6.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 28, 2018 Filed Jul 31, 2018 20:15 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001704739-18-000037 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,800 F1 · shares: Represents the grant of restricted stock units ("RSUs"). The RSUs vest as to one-third of the shares on July 27, 2019 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:41 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001704739-18-000016 · edgar.xml · derivative · entry 6 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt pursuant to Rule 16b-3. F3 · derivative.exercise_date: 1/12th of the shares vested on 8/1/2011 and each month thereafter Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:41 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001704739-18-000016 · edgar.xml · derivative · entry 5 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt pursuant to Rule 16b-3. F2 · derivative.exercise_date: 1/12th of the shares vested on 8/2/2012 and each month thereafter Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:41 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionCommon Stock | 5,000 | $3.95 | $19,750.00 |
DisclosureSEC source: 0001704739-18-000016 · edgar.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:41 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionCommon Stock | 5,000 | $3.75 | $18,749.50 |
DisclosureSEC source: 0001704739-18-000016 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionNonqualified Stock Option · Derivative | 3,000 | $24.50 Strike: $24.50 | $73,500.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · derivative · entry 8 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2020-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionNonqualified Stock Option · Derivative | 5,000 | $10.69 Strike: $10.69 | $53,450.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · derivative · entry 7 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | SaleCommon Stock, $0.001 par value per share | 3,000 | $35.91 | $107,730.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · nonDerivative · entry 4 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 89,402 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionCommon Stock, $0.001 par value per share | 3,000 | $24.50 | $73,500.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · nonDerivative · entry 3 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 92,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | SaleCommon Stock, $0.001 par value per share | 5,000 | $35.91 | $179,550.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · nonDerivative · entry 2 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 89,402 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:36 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionCommon Stock, $0.001 par value per share | 5,000 | $10.69 | $53,450.00 |
DisclosureSEC source: 0000878526-18-000079 · wf-form4_152667572852427.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 94,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 16, 2017 00:06 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 5,000 | $7.84 | $39,200.00 |
DisclosureSEC source: 0001704739-17-000034 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 83,944 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.82 to $7.85, inclusive. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 16:37 UTC | NATUS MEDICAL INC BABY · Entity 125256 | SaleCommon Stock, $0.001 par value per share | 5,000 | $41.01 | $205,050.00 |
DisclosureSEC source: 0000878526-17-000100 · wf-form4_151078180844553.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 89,402 F1 · price: This transaction was executed in multiple trades at prices ranging from $41.00 to $41.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 22:42 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 1,800 | $9.42 | $16,956.00 |
DisclosureSEC source: 0001704739-17-000028 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,434 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.41 to $9.42, inclusive. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 00:44 UTC | IRIDEX CORP IRIX · Entity 7882 | OtherCommon Stock | 4,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001704739-17-000025 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,634 Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 18:19 UTC | NATUS MEDICAL INC BABY · Entity 125256 | SaleCommon Stock, $0.001 par value per share | 3,000 | $34.10 | $102,300.00 |
DisclosureSEC source: 0000878526-17-000071 · wf-form4_150283553769378.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 94,402 Read SEC document |
| July 24, 2017 Filed Jul 27, 2017 16:23 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionStock Option Right to Buy · Derivative | 157,000 | $0.00 Strike: $9.54 | $0.00 |
DisclosureSEC source: 0001704739-17-000017 · edgar.xml · derivative · entry 3 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,000 Underlying: Common Stock · 157,000 shares Expires 2024-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3. F3 · derivative.exercise_date: Shares subject to the option vest over a period of 48 months with 1/4th of the total number of shares vesting on the first anniversary of the grant date and 1/48th of the total number of shares vesting each month thereafter. Read SEC document |
| July 24, 2017 Filed Jul 27, 2017 16:23 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 15,000 | $9.54 | $143,100.00 |
DisclosureSEC source: 0001704739-17-000017 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,931 F1 · shares: Restricted stock units vest over a period of 48 months with 1/4th of the total number of units vesting on the first anniversary of the grant date and 1/48th of the total number of units vesting each month thereafter. Restriced stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 13:02 UTC | NATUS MEDICAL INC BABY · Entity 125256 | GrantCommon Stock, $0.001 par value per share | 4,100 | $35.60 | $145,960.00 |
DisclosureSEC source: 0000878526-17-000060 · wf-form4_149823735059596.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,410 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 16:32 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionNonqualified Stock Option · Derivative | 5,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0000878526-17-000025 · wf-form4_148952353138765.xml · derivative · entry 4 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 16:32 UTC | NATUS MEDICAL INC BABY · Entity 125256 | Exercise / conversionCommon Stock, $0.001 par value per share | 5,000 | $16.38 | $81,900.00 |
DisclosureSEC source: 0000878526-17-000025 · wf-form4_148952353138765.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 97,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 22:10 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionStock Option Right to Buy · Derivative | 5,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001261380-17-000002 · edgar.xml · derivative · entry 3 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3. F2 · derivative.exercise_date: Shares subject to the option are fully vested and immediately exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.